정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
---|---|---|---|---|---|---|---|---|---|---|---|
2004 | Active, not recruiting | Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19 in Belarus | Covid19 | Biological: Gam-COVID-Vac Other: Placebo |
Phase 3 | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation, Russian Direct Investment Fund, CRO: iPharma | OTHER | 100 | All | 18 Years ~ 60 Years | Health Institution "14th Central Regional Polyclinic of the Partisan district of Minsk", Minsk, Belarus Health Institution "19th Central Regional Polyclinic of the Pervomaysk district of Minsk", Minsk, Belarus Health Institution "1st Central Regional Clinical Polyclinic of the Central district of Minsk", Minsk, Belarus Health Institution "28th Regional Polyclinic of Minsk", Minsk, Belarus Health Institution "4th City Polyclinic of Minsk", Minsk, Belarus Health Institution "5th City Clinical Polyclinic of Minsk", Minsk, Belarus Health Institution "Minsk Order of the Red Banner of Labor Regional Clinical Hospital, Minsk, Belarus Health Institution "Vitebsk Regional Clinical Hospital", Vitebsk, Belarus |
2003 | Recruiting | Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia | Novel Coronavirus Pnuemonia | Drug: favipiravir tablets+chloroquine phosphatetablets tablets Drug: Favipiravir tablets Drug: Placebo |
Phase 3 | Beijing Chao Yang Hospital | OTHER | 150 | All | 18 Years ~ 75 Years | Beijing Chaoyang hospital, Beijing, Beijing, China |
2002 | Recruiting | Clinical Trial of Favipiravir Treatment of Patients With COVID-19 | SARS-CoV-2 Infection | Drug: Favipiravir | Phase 3 | University of Pecs, HECRIN Consortium, Hungarian Ministry of Innovation and Technology | OTHER | 150 | All | 18 Years ~ 74 Years | Department of Pulmonology Semmelweis University, Budapest, Hungary National Koranyi Institute for Pulmonology, Budapest, Hungary Institute of Infectology, University of Debrecen, Debrecen, Hungary 1st Department of Medicine, University of Pecs, Pecs, Hungary First Department of Internal Medicine, University of Szeged, Szeged, Hungary |
2001 | Recruiting | Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus(COVID-19) Vaccine (CHO Cell) | Coronavirus Disease 2019 | Biological: Recombinant new coronavirus vaccine (CHO cell) | Phase 2 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | INDUSTRY | 400 | All | 3 Years ~ 17 Years | Hunan Provincial Center for Disease Control and Prevention, Changsha, Hunan, China |
2000 | Recruiting | Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults | COVID-19 | Biological: SARS-CoV-2 Inactivated Vaccine Biological: The SARS-CoV-2 Inactivated Vaccine |
Phase 4 | Sinovac Research and Development Co., Ltd. | INDUSTRY | 1400 | All | 18 Years ~ 59 Years | Beijing Centers for Diseases Control and Prevention, Beijing, China |
1999 | Completed | Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection | Covid19 | Drug: Ivermectin and Doxycycline Drug: Standard of care |
Phase 3 | Dhaka Medical College | OTHER | 400 | All | 18 Years | Dhaka Medical College, Dhaka, Bangladesh |
1998 | Recruiting | Clinical Trial of Mycobacterium w in COVID-19 Positive Patients, Hospitalized But Not Critically Ill | COVID-19 | Drug: Suspension of heat killed (autoclaved) Mycobacterium w Other: Placebo |
Phase 3 | Cadila Pharnmaceuticals, Council of Scientific and Industrial Research, India | INDUSTRY | 480 | All | 18 Years | All India Institute of Medical Science, Raipur, Raipur, Chhattisgarh, India All India Institute of Medical Sciences, Bhopal, Bhopal, India Post Graduate Institute of Medical Education and Research, Chandigarh, India All India Institute of Medical Sciences, Delhi, Delhi, India |